Loading viewer...
investor_presentation
Format: PDF investor_presentation
Moderna's 2022 Annual R&D Day presentation covering the company's mRNA science platform and pipeline developments. The deck outlines upcoming clinical trial timelines for vaccine and therapeutic candidates targeting infectious diseases and rare genetic disorders, including programs in RSV, CMV, PCV, and combination vaccines.
conference
25 Pages
investor_presentation
34 Pages
Groupama Assurances Mutuelles
investor_presentation
Ducommun
investor_presentation
4D Pharma